Expert comment: International Clinical Trials Day
17 May 2019
Experts from the University of the Sunshine Coast Clinical Trials Centre are available to comment ahead of International Clinical Trials Day on Monday 20 May.
Current clinical trials being managed by the USC Clinical Trials team include; cardiovascular disease, cold agglutin disease, common cold, crohn’s disease, viral respiratory illness, heart failure, cytomegalovirus vaccine and paediatric flu vaccine.
A clinical trial is a research study performed by experts from the medical field. It aims to determine if a new drug, diet, or a medical treatment device is safe and effective for the use.
The following experts are available for comment:
Lucas Litewka, Director USC Clinical Trials Centre: 07 5456 5265 or llitewka@usc.edu.au
Dr Nova Evans, Clinical Trial Doctor USC Clinical Trials Centre: nevans3@usc.edu.au
Background on the USC Clinical Trials Centre:
The University of the Sunshine Coast has established the USC Clinical Trials Centre, a world-class, purpose-built clinical trials centre at Sippy Downs and at Morayfield.
The centre is built on a clinical framework that gives industry unprecedented access to a network of private doctors and their patients on the Sunshine Coast and Moreton Bay.
Since operations began in 2016, the centre continues to increase the region’s clinical research capacity and deliver innovative and regionally relevant research in consultation with key stakeholders including local private healthcare professionals, the community, the biopharmaceutical industry and other key thought leaders.
Related articles
Clinical trial of experimental new treatment for chronic plaque psoriasis
28 JanUSC Clinical Trials is about to begin a study of an experimental new treatment for mild to moderate chronic plaque psoriasis, a common skin condition.
USC Clinical Trials seeks healthy volunteers for malaria study
5 JanUSC Clinical Trials has partnered with the QIMR Berghofer Medical Research Institute in Brisbane to investigate whether an approved anti-malarial drug can be used more extensively to counter malaria – a disease that claims more than 400,000 lives worldwide each year.
Contact the USC media team
| Name | Position | Phone | |
|---|---|---|---|
| Terry Walsh | Manager, Media and Messaging | twalsh@usc.edu.au | +61 7 5430 1160 |
| Janelle Kirkland | Media Relations Coordinator | jkirklan@usc.edu.au | +61 7 5459 4553 |
| Clare McKay | Media Relations Officer (Regional) | cmckay@usc.edu.au | +61 7 5456 5669 |